81 related articles for article (PubMed ID: 20108388)
1. Novel human pathological mutations. Gene symbol: NCF2. Disease: Chronic granulomatous disease.
Köker MY
Hum Genet; 2010 Jan; 127(1):113. PubMed ID: 20108388
[No Abstract] [Full Text] [Related]
2. Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations.
Köker MY; Sanal O; van Leeuwen K; de Boer M; Metin A; Patiroğlu T; Ozgür TT; Tezcan I; Roos D
Eur J Clin Invest; 2009 Oct; 39(10):942-51. PubMed ID: 19624736
[TBL] [Abstract][Full Text] [Related]
3. Gene symbol: CYBB. Disease: X-linked chronic granulomatous disease.
Stasia MJ
Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818813
[No Abstract] [Full Text] [Related]
4. Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease.
Köker MY; van Leeuwen K; de Boer M; Celmeli F; Metin A; Ozgür TT; Tezcan I; Sanal O; Roos D
Eur J Clin Invest; 2009 Apr; 39(4):311-9. PubMed ID: 19292887
[TBL] [Abstract][Full Text] [Related]
5. Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease.
Teimourian S; Zomorodian E; Badalzadeh M; Pouya A; Kannengiesser C; Mansouri D; Cheraghi T; Parvaneh N
Br J Haematol; 2008 Jun; 141(6):848-51. PubMed ID: 18422995
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene.
von Goessel H; Hossle JP; Seger R; Gungor T
Exp Hematol; 2006 Apr; 34(4):528-35. PubMed ID: 16569599
[TBL] [Abstract][Full Text] [Related]
7. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase.
Roos D; de Boer M; Köker MY; Dekker J; Singh-Gupta V; Ahlin A; Palmblad J; Sanal O; Kurenko-Deptuch M; Jolles S; Wolach B
Hum Mutat; 2006 Dec; 27(12):1218-29. PubMed ID: 16972229
[TBL] [Abstract][Full Text] [Related]
8. The search for a genetic defect in Polish patients with chronic granulomatous disease.
Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease.
Barese CN; Copelli SB; De Matteo E; Zandomeni R; Salgueiro F; Di Giovanni D; Heyworth P; Rivas EM
Pediatr Blood Cancer; 2005 Apr; 44(4):420-2. PubMed ID: 15468310
[TBL] [Abstract][Full Text] [Related]
10. A new autosomal recessive, heterozygous pair of mutations of CYBA in a patient with chronic granulomatous disease.
Chang YH; Yu HH; Lau YL; Chan KW; Chiang BL
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):183-5. PubMed ID: 20674832
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations.
Nunoi H; Ishibashi F; Mizukami T; Hidaka F
Jpn J Infect Dis; 2004 Oct; 57(5):S25-6. PubMed ID: 15507763
[TBL] [Abstract][Full Text] [Related]
12. Hematologically important mutations: X-linked chronic granulomatous disease (second update).
Heyworth PG; Curnutte JT; Rae J; Noack D; Roos D; van Koppen E; Cross AR
Blood Cells Mol Dis; 2001; 27(1):16-26. PubMed ID: 11162142
[No Abstract] [Full Text] [Related]
13. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox.
Patiño PJ; Perez JE; Lopez JA; Condino-Neto A; Grumach AS; Botero JH; Curnutte JT; García de Olarte D
Hum Mutat; 1999; 13(1):29-37. PubMed ID: 9888386
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic analysis of phagocyte oxidase cytochrome b558 mutations leading to chronic granulomatous disease.
Hossle JP; Berthet F; Erny C; Seger RA
Immunodeficiency; 1993; 4(1-4):303-6. PubMed ID: 8167722
[No Abstract] [Full Text] [Related]
15. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update).
Cross AR; Noack D; Rae J; Curnutte JT; Heyworth PG
Blood Cells Mol Dis; 2000 Oct; 26(5):561-5. PubMed ID: 11112388
[No Abstract] [Full Text] [Related]
16. Genetic and biochemical background of chronic granulomatous disease.
Jurkowska M; Bernatowska E; Bal J
Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
[TBL] [Abstract][Full Text] [Related]
17. Chronic granulomatous disease: mutations in cytochrome b558.
Roos D; De Boer M; De Klein A; Bolscher BG; Weening RS
Immunodeficiency; 1993; 4(1-4):289-301. PubMed ID: 8167720
[No Abstract] [Full Text] [Related]
18. A novel mutation in NCF2 associated with autoimmune disease and a solitary late-onset infection.
Chou J; Hsu JT; Bainter W; Al-Attiyah R; Al-Herz W; Geha RS
Clin Immunol; 2015 Dec; 161(2):128-30. PubMed ID: 26272171
[TBL] [Abstract][Full Text] [Related]
19. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
[TBL] [Abstract][Full Text] [Related]
20. Progress toward effective gene therapy for chronic granulomatous disease.
Malech HL; Choi U; Brenner S
Jpn J Infect Dis; 2004 Oct; 57(5):S27-8. PubMed ID: 15507764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
